ALUMNI AD Study Design: Evaluation of Subcutaneous Gantenerumab in Historically Underrepresented US Populations With Early Symptomatic Alzheimer's Disease

被引：0
|
作者：
Seleri, Sheila [1 ]
Brangman, Sharon [2 ]
Henderson, J. Neil [3 ]
Parker, Monica [4 ]
Monroe, Stephanie [5 ]
Mintzer, Jacobo [6 ]
Wise-Brown, Alexandria [1 ]
Grundman, Michael [7 ]
Smith, Janice [8 ]
Doody, Rachelle [8 ]
Lin, Helen [1 ]
Assman, Beverly [1 ]
Rippon, Gregory [1 ]
机构：
[1] Genentech Inc, Roche Grp, San Francisco, CA USA
[2] SUNY Upstate Med Univ, Syracuse, NY USA
[3] Univ Minnesota, Minneapolis, MN USA
[4] Emory Univ, Sch Med, Goizueta Alzheimers Dis Res Ctr, Atlanta, GA USA
[5] UsAgainstAlzheimers, Washington, DC USA
[6] Med Univ South Carolina, Charleston, SC USA
[7] Global R&D Partners LLC, San Diego, CA USA
[8] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203813
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S26.006
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer ' s disease
    Wise-Brown, Alexandria
    Brangman, Sharon A.
    Henderson, J. Neil
    Willis-Parker, Monica
    Monroe, Stephanie
    Mintzer, Jacobo E.
    Grundman, Michael
    Smith, Janice
    Doody, Rachelle S.
    Lin, Helen
    Assman, Beverly
    Rippon, Gregory A.
    Gonzales, Rozanno
    Assuncao, Sheila Seleri
    ECLINICALMEDICINE, 2024, 73
  • [2] SKYLINE STUDY DESIGN EFFICACY AND SAFETY OF GANTENERUMAB IN PARTICIPANTS AT-RISK FOR ALZHEIMER'S DISEASE
    Bullain, Szofia
    Delmar, Paul
    Sperling, Reisa
    Reiman, Eric M.
    Aisen, Paul
    Wojtowicz, Jakub
    Bittner, Tobias
    Ashford, Elizabeth
    Doody, Rachelle S.
    Ostrowitzki, Susanne
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [3] GRADUATE I AND II: Findings of Two Phase III Randomized Placebo-controlled Studies Assessing the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer's Disease (AD)
    Smith, Janice
    Donohue, Michael C.
    Gruendl, Elisabeth
    Grimmer, Timo
    Perry, Richard J.
    Black, Sandra E.
    Salloway, Stephen
    Lyons, Marco
    Rutten-Jacobs, Loes
    Bittner, Tobias
    Blennow, Kaj
    Pelentrides, Chris
    Barkhof, Frederik
    Tonietto, Matteo
    Baudler-Klein, Monika
    Fontoura, Paulo
    Doody, Rachelle S.
    NEUROLOGY, 2023, 100 (17)
  • [4] Alzheimer's Disease Linkage to Evidence (AD-LINE) Study Early Results: Linking Real-World Claims Data to Phase III GRADUATE Study of Gantenerumab
    Wallick, Chris
    Fillit, Howard
    Tcheremissine, Oleg
    Abbass, Ibrahim M.
    Ng, Carmen
    To, Tu My
    Seleri, Sheila
    NEUROLOGY, 2023, 100 (17)
  • [5] Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab
    Fillit, H.
    Assuncao, S. Seleri
    Majda, Thomas
    Ng, C. D.
    To, T. M.
    Abbass, I. M.
    Raimundo, K.
    Wallick, C.
    Tcheremissine, O. V.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (05): : 1251 - 1259
  • [6] Risk factors and early signs of Alzheimer's disease in a family study sampleRisk of AD
    R. Heun
    H. Kölsch
    F. Jessen
    European Archives of Psychiatry and Clinical Neuroscience, 2006, 256 : 28 - 36
  • [7] Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study
    Muurling, Marijn
    de Boer, Casper
    Kozak, Rouba
    Religa, Dorota
    Koychev, Ivan
    Verheij, Herman
    Nies, Vera J. M.
    Duyndam, Alexander
    Sood, Meemansa
    Froehlich, Holger
    Hannesdottir, Kristin
    Erdemli, Gul
    Lucivero, Federica
    Lancaster, Claire
    Hinds, Chris
    Stravopoulos, Thanos G.
    Nikolopoulos, Spiros
    Kompatsiaris, Ioannis
    Manyakov, Nikolay V.
    Owens, Andrew P.
    Narayan, Vaibhav A.
    Aarsland, Dag
    Visser, Pieter Jelle
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [8] Remote monitoring technologies in Alzheimer’s disease: design of the RADAR-AD study
    Marijn Muurling
    Casper de Boer
    Rouba Kozak
    Dorota Religa
    Ivan Koychev
    Herman Verheij
    Vera J. M. Nies
    Alexander Duyndam
    Meemansa Sood
    Holger Fröhlich
    Kristin Hannesdottir
    Gul Erdemli
    Federica Lucivero
    Claire Lancaster
    Chris Hinds
    Thanos G. Stravopoulos
    Spiros Nikolopoulos
    Ioannis Kompatsiaris
    Nikolay V. Manyakov
    Andrew P. Owens
    Vaibhav A. Narayan
    Dag Aarsland
    Pieter Jelle Visser
    Alzheimer's Research & Therapy, 13
  • [9] Risk factors and early signs of Alzheimer's disease in a family study sample -: Risk of AD
    Heun, R
    Kölsch, H
    Jessen, F
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2006, 256 (01) : 28 - 36
  • [10] Qualitative research and literature review support the integrated Alzheimer's Disease Rating Scale (iADRS) content validity in early symptomatic AD
    Delbecque, Laure
    Elliott, Emma
    Cleanthous, Sophie
    Heinrich, Phoebe
    Cano, Stefan
    Wessels, Alette M.
    Atkins, Alexandra S.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2025, 12 (04):
12345